August 30, 2014 12:47 PM ET

Pharmaceuticals

Company Overview of Cadence Pharmaceuticals Inc.

Executive Profile

Theodore R. Schroeder

Co-Founder, Chief Executive Officer, President and Director, Cadence Pharmaceuticals Inc.
AgeTotal Calculated CompensationThis person is connected to 4 Board Members in 4 different organizations across 4 different industries.

See Board Relationships
59$1,700,225
As of Fiscal Year 2012

Background

Mr. Theodore R. Schroeder, also known as Ted, co-founded Cadence Pharmaceuticals Inc., in May 2004 and has been its President and Chief Executive Officer since May 2004. Prior to founding Cadence, Mr. Schroeder served as the Senior Vice President of North American Sales and Marketing at Elan Pharmaceuticals, Inc., with responsibility for all pharmaceutical commercial operations, including the primary care, neurology, and hospital franchises. Previously, he served as ...

Corporate Headquarters

12481 High Bluff Drive
San Diego, California 92130

United States

Phone: 858-436-1400
Fax: 858-436-1401

Board Members Memberships

Director
2004-Present
Co-Founder, Chief Executive Officer, President and Director
2009-Present
Independent Director and Chairman of Compensation Committee
2014-Present
Director

Education

BS
Rutgers, The State University of New Jersey

Other Affiliations

Annual Compensation

Salary$538,500
Total Annual Compensation$538,500

Stocks Options

Exercisable Options$1,588,134
Exercisable Options Value$1,962,522
Unexercisable Options$821,875
Unexercisable Options Value$448,000
Total Value of Options$2,410,521
Total Number of Options$2,410,009

Total Compensation

Total Annual Cash Compensation$922,181
Total Short Term Compensation$538,500
Total Calculated Compensation$1,700,225
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Cadence Pharmaceuticals Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.